BioNTech's mRNA Cancer Vaccine Has Started Phase 2 Clinical Trial

Enviado por Fabio el 2021-12-21 19:57:43 | Host: interestingengineering.com

Colorectal cancer was chosen by BioNTech as an experimental vaccine target due to the disease's relatively high relapse rate.

Twitter Facebook Whatsapp
 

Ciencia: biontech, cancer, clinical trial, mrna, vaccine

Comentarios